Company intelligence / Profile preview

Chelatec

Saint-Herblain, Pays de la Loire, Francechelatec.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Chelatec provides custom radiolabeling and preclinical investigation services to pharmaceutical and biotechnology companies. It specializes in radioactive tracer-based ADME/PK studies, bioanalyses, and R&D support for radiopharmaceuticals. The company does not have its own clinical pipeline but supports client drug development projects from discovery through preclinical stages.

Modalities: RadiopharmaceuticalRadioligandSmall molecule (radiosynthesis)Biologic (radiolabeling of antibodies, proteins, peptides)
Industry: Drug Discovery Services

Partnerships

Multiple pharmaceutical and biotech sponsors as clients worldwide (>110 customers in >17 countries)

Beyond the preview

Go deeper on Chelatec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chelatec.

Explore the full profile